Browsing Tag
NSE:ASTEC
1 post
Astec LifeSciences (ASTEC) reports narrowed Q3 loss as CDMO momentum drives positive EBITDA
Astec LifeSciences posts ₹125.5 crore in Q3 FY26 revenue with positive EBITDA. Find out how CDMO gains and margin recovery are reshaping the outlook today.